Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Vanda Pharmaceuticals Inc. (VNDA)

Index:

Nasdaq Composite

Add To Portfolio

$ 0.00

Closing Price Chg:

$0.69
52 Week High: $9.52
52 Week Low: $4.18

Currency: US Dollars
Shares Issued: 52.38m
Volume: 0

RiskGrade: 297
Beta: 0.02

Select chart: 1 week | 6 month

Current

1 week

Forecasts

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-26	262.15	(147.80)	(226.75)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-27	356.50	(61.05)	(76.75)¢	n/a	n/a	n/a	n/a	0.0%

Forecast Ratios

Year Ending	Revenue/Share	Price/Revenue per Share
31-Dec-26	$5.00	1.17
31-Dec-27	$6.81	0.86

Trends & Recommendations

	Current	1 week ago	1 month ago	3 months ago	6 months ago	1 year ago
Revenue ($m)
31-Dec-2026	262	262	n/a	n/a	271	n/a
31-Dec-2027	356	356	n/a	n/a	347	n/a

Earnings
31-Dec-2026	n/a	n/a	n/a	n/a	n/a	n/a
31-Dec-2027	n/a	n/a	n/a	n/a	n/a	n/a

Dividend
31-Dec-2026	n/a	n/a	n/a	n/a	n/a	n/a
31-Dec-2027	n/a	n/a	n/a	n/a	n/a	n/a

Recommendations
Strong Buy	0	0	0	0	0	0
Buy	3	3	0	0	3	0
Neutral	1	1	0	0	1	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
No. of Brokers	4	4	0	0	4	0

Average Rec	6.88	6.88	n/a	n/a	6.88	n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

VNDA Market Data

Currency	US Dollars
Share Price	$ 5.85
Closing Price Change	$ 0.69
% Change	0.00 %
52 Week High	$9.52
52 Week Low	$4.18
Volume	0
Shares Issued	52.38m
Beta	0.02
RiskGrade	297